The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mesniankina O.A.

Federal State Institution "Institute for Lepra Research", Russian Federal Agency of Public Health and Social Development, Astrakhan

Degtiarev O.V.

Federal State Institution "Institute for Lepra Research", Russian Federal Agency of Public Health and Social Development, Astrakhan

Naumov V.Z.

Federal State Institution "Institute for Lepra Research", Russian Federal Agency of Public Health and Social Development, Astrakhan

Hepatic pathology associated with chronic dermatoses of infectious and autoimmune origin and methods of its correction

Authors:

Mesniankina O.A., Degtiarev O.V., Naumov V.Z.

More about the authors

Read: 4285 times


To cite this article:

Mesniankina OA, Degtiarev OV, Naumov VZ. Hepatic pathology associated with chronic dermatoses of infectious and autoimmune origin and methods of its correction. Russian Journal of Clinical Dermatology and Venereology. 2010;8(5):126‑130. (In Russ.)

References:

  1. Minushkin O.N. Nekotorye gepatoprotektory v lechenii zabolevanii pecheni. Lech vrach 2002;6:55-58.
  2. Okovityi S.V. Klinicheskaya farmakologiya gepatoprotektorov. FARMindeks: Praktika 2002;3:33-58.
  3. Kozhnye i venericheskie bolezni. Rukovodstvo dlya vrachei. V 2 t. Pod red. Yu.K. Skripkina, V.N. Mordovtseva M: Meditsina 1999;1600.
  4. Uchaikin V.F., Archakov A.I., Ipatova O.M. i dr. Fosfogliv. Lechenie i zashchita pecheni. Posobie dlya vrachei. M 2004.
  5. Povalii T.M., Loginova T.K., Sharapova G.Ya., Gusev S.A. Kolichestvennyi analiz kholesterina membran keratinotsitov epidermisa pri psoriaze. Vestn dermatol i venerol 1997;1:4-6.
  6. Ipatova O.M. Fosfogliv: mekhanizm deistviya i primenenie v klinike. M 2005;318.
  7. Korsunskaya I.M., Reznikova M.M. Strategiya terapii psoriaticheskoi bolezni. Consilium Medicum 2004;3:176-179.
  8. Butov Yu.S., Khrustaleva E.A., Fedorova E.G. i dr. Uroven' lipidov i pokazateli kletochnogo immuniteta u bol'nykh psoriazom (soobshchenie 1). Ros zhurn kozhn i ven bol 1999;2:11-14.
  9. Dyurd' P.M. Porazhenie pecheni pri psoriaticheskoi eritrodermii. Vestn dermatol i venerol 1983;2:66-67.
  10. Baltabaev M.K., Khamidov Sh.A., Valikhanov U.A., Khamidov F.Sh. Psoriaz i metabolizm zhelchnykh kislot. Vestn dermatol i venerol 2005;4:25-28.
  11. Nikiforov A.P. Aktivnost' fermentov syvorotki krovi u muzhchin i zhenshchin pri nekotorykh patologicheskikh sostoyaniyakh. Klin lab diagn 1995;1:14-15.
  12. Butov Yu.S., Khrustaleva E.A. Fedorova E.G. i dr. Uroven' lipidov i pokazateli kletochnogo immuniteta u bol'nykh psoriazom. Ros zhurn kozhn i ven bol 1999;2:11-14.
  13. Butov Yu.S., Vasenova V.Yu., Il'ina T.A., Khrustaleva E.A. Fosfogliv v terapii ryada dermatozov. Rus med zhurn 2006;14:5:353-356.
  14. Loginov V.K. Leproznoe porazhenie pecheni: Avtoref. dis. ... d-ra med. nauk. M 1969;19.
  15. Zadneprovskaya E.A. Korrektsiya skhem lecheniya bol'nykh leproi v zavisimosti ot aktivnosti monooksigenaznoi i atsetiltransferaznoi fermentnykh sistem pecheni: Avtoref. dis. ... kand. med. nauk. M 2004;22.
  16. Languillon J., Plagnol H., Saboret J. et al. Le foie du lepreux. Bulletin de la Societe de Pathologie Exotique 1966;59:1:22.
  17. Okovityi S.V., Shulenin S.N. Klinicheskaya farmakologiya gepatoprotektorov. St-Peterburg 2006;4-6.
  18. Karkishchenko N.N. Klinicheskaya i ekologicheskaya farmakologiya v terminakh i ponyatiyakh. M 1995;304.
  19. Bueverov A.O. Mesto gepatoprotektorov v lechenii zabolevanii pecheni. Bol organov pishchevareniya 2001;1:16-18.
  20. Shul'pekova Yu.O. Flavonoidy rastoropshi pyatnistoi v lechenii zabolevanii pecheni. Rus med zhurn 2004;5:248-250.
  21. Cuendet M., Pezzuto M. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Int 2000;17:109-157.
  22. Ushkalova E.A. Problemy primeneniya gepatoprotektorov. Farmateka 2004;4:45-55.
  23. Ushkalova E.A. Mesto essentsial'nykh fosfolipidov v sovremennoi meditsine. Farmateka 2003;10:40-47.
  24. Podymova S.D., Nadinskaya M.Yu. Otsenka effektivnosti preparata geptral u bol'nykh s khronicheskimi diffuznymi zabolevaniyami pecheni s sindromom vnutripechenochnogo kholestaza. Klin med 1998;10:45-48.
  25. Combs G.F., Combs S.B. The role of selenum in nutrition. Orlando 1986;532-538.
  26. Gorbakov V.V., Galik V.P., Kirillov S.M. Opyt primeneniya geptrala v lechenii diffuznykh zabolevanii pecheni. Ter arkh 1998;10:82-86.
  27. Reizis A.R., Nurmukhametova E.A. Vozmozhnosti i perspektivy primeneniya geptrala pri lechenii porazhenii pecheni u detei s onkogematologicheskimi zabolevaniyami. Ter arkh 1998;10:48-51.
  28. Lyubshina O.V., Grechko V.E., Vertkin A.L., Maev I.V. Effektivnost' razlichnykh gepatoprotektorov pri pechenochnoi entsefalopatii. Klin med 1999;10:17-20.
  29. Maev I.V., Gurevich K.G. Lechenie i profilaktika pechenochnoi entsefalopatii gepatoprotektorami. Ros zhurn gastroenterol gepatol koloproktol 2001;4:41-45.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.